Abbott's Device Leader Pay Climbs Again with Double-Digit Sales Growth

Abbott EVP and Medical Devices Group President Lisa Earnhardt's pay package increased more than 20% in 2025 as device sales maintained their double-digit growth.

Apr. 15, 2026 at 8:06pm

Got story updates? Submit your updates here. ›

A photorealistic studio still-life image of a sleek, modern medical instrument made from polished metal and glass, floating elegantly on a clean, monochromatic background with dramatic lighting and sharp shadows to convey the precision and innovation of Abbott's technology.Abbott's innovative medical devices drive the company's double-digit sales growth and executive compensation increases.Minneapolis Today

Abbott, the world's eighth-largest medical device company, reported compensation increases for its CEO and other executives, including a 23% jump in pay for Lisa Earnhardt, the EVP and President of the Medical Devices Group. This comes as Abbott's medical device sales grew 12% to $21.39 billion in 2025, the third consecutive year of double-digit growth.

Why it matters

Recruiting and retaining top talent is crucial in the medtech industry, and Abbott's executive compensation increases reflect the company's efforts to reward and incentivize its leadership team as it continues to drive strong sales growth in its medical device business.

The details

Abbott Chair and CEO Robert Ford received $24.2 million in total compensation for 2025, up 6% from the prior year. Other executives who saw pay increases include Finance EVP and CFO Phil Bourdreau (up 9% to $9.1 million) and Established Pharmaceuticals and Nutritional Products Group President Daniel Salvadori (up 12% to $6.5 million). The company said approximately 86% of executive pay is performance-based, directly tying compensation to company performance and shareholder returns.

  • Abbott reported its 2025 executive compensation figures in April 2026.
  • Abbott's medical device sales grew for the third consecutive year in 2025.

The players

Robert Ford

Abbott Chair and CEO who received $24.2 million in total compensation for 2025, up 6% from the prior year.

Phil Bourdreau

Abbott Finance EVP and CFO who received $9.1 million in total compensation for 2025, up 9% from the prior year.

Lisa Earnhardt

Abbott EVP and Medical Devices Group President who received $8.1 million in total compensation for 2025, up 23% from the prior year.

Hubert Allen

Former Abbott EVP, General Counsel and Secretary who received $7 million in total compensation for 2025, down 12% from the prior year before retiring in June 2025.

Chris Scoggins

Abbott Diabetes Care EVP who received $6.6 million in total compensation for 2025 after being promoted to his position in December 2024.

Got photos? Submit your photos here. ›

What’s next

Abbott investors will cast advisory 'say-on-pay' votes on the company's executive compensation practices at the April 24, 2026 annual meeting.

The takeaway

Abbott's executive compensation increases, particularly for its medical device leadership, reflect the company's efforts to retain top talent and reward performance as it continues to drive strong sales growth in its core device business.